MedTrace Logo

Progesterone Rise in Agonist Versus Antagonist in Vitro Fertilization (IVF) Cycles

NCT01191710 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2010-09-15

No results posted yet for this study

Summary

The aim is to explore whether the incidence of progesterone rise in the late follicular phase differs between GnRH-agonist and GnRH-antagonist protocols for IVF and whether this has an impact on the probability of pregnancy achievement.

Conditions

  • Pregnancy Outcome After In Vitro Fertilization (IVF)

Interventions

OTHER

In vitro fertilization

In vitro fertilization procedure with gonadotropin induced follicular ovarian stimulation

Sponsors & Collaborators

  • BioGenesis

    collaborator INDUSTRY

  • Universitair Ziekenhuis Brussel

    lead OTHER

Principal Investigators

  • Basil Tarlatzis, MD · BioGenesis

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
39 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-01-31
Primary Completion
2011-01-31
Completion
2011-01-31

Countries

  • Greece

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01191710 on ClinicalTrials.gov